ATS 2018 International Conference - Mobile

Proprotein Convertase Subtilisin/Kexin Type 9 Loss-of-Function Genotype Is Beneficial to Septic Shock Outcome While HMG-CoA Reductase Loss-of-Function Genotype Is Not [Board No. 720]

Location: Board no. 720

Session Type: RAPiD: Rapid Abstract Poster Discussion Session

Monday

May

21

9:15 AM

11:15 AM

Speaker(s)/Author(s)

John H. Boyd

MD
Centre for Heart and Lung Innovation - St. Paul's Hospital - University of British Columbia;Centre for Heart and Lung Innovation, St. Paul’s Hospital, University of British Columbia;Centre for Heart L

Hyejin Kong

BSc
Centre for Heart and Lung Innovation - St. Paul's Hospital - University of British Columbia;Centre for Heart and Lung Innovation, St. Paul’s Hospital, University of British Columbia;Centre for Heart L

James A. Russell

MD
Centre for Heart and Lung Innovation - St. Paul's Hospital - University of British Columbia;Centre for Heart and Lung Innovation, St. Paul’s Hospital, University of British Columbia;Centre for Heart L

Keith R. Walley

MD
Centre for Heart and Lung Innovation - St. Paul's Hospital - University of British Columbia;Centre for Heart and Lung Innovation, St. Paul’s Hospital, University of British Columbia;Centre for Heart L

View Abstract

Proprotein Convertase Subtilisin/Kexin Type 9 Loss-of-Function Genotype Is Beneficial to Septic Shock Outcome While HMG-CoA Reductase Loss-of-Function Genotype Is Not

Parent Sessions

B22 - CRITICAL CARE: MICROBIOME, GENETICS, AND OTHER BIOMARKERS IN ACUTE CRITICAL ILLNESS...
05-21-2018 9:15 AM - 11:15 AM